We are live on ! Find out more
OM icon

Outset Medical

142 hedge funds and large institutions have $2.5B invested in Outset Medical in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more call options, than puts

Call options by funds: $4.11M | Put options by funds: $841K

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

76% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 34

10% more funds holding

Funds holding: 129142 (+13)

8% more capital invested

Capital invested by funds: $2.31B → $2.5B (+$196M)

0.59% more ownership

Funds ownership: 6.71%7.3% (+0.59%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
142
Holders Change
+13
Holders Change %
+10.08%
% of All Funds
2.49%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
26
Increased
60
Reduced
34
Closed
13
Calls
$4.11M
Puts
$841K
Net Calls
+$3.27M
Net Calls Change
+$3.27M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$343M +$2.26M +3,318 +0.7%
BlackRock
2
BlackRock
New York
$239M +$45.4M +66,621 +26%
DCP
3
D1 Capital Partners
New York
$226M
Vanguard Group
4
Vanguard Group
Pennsylvania
$198M +$13.6M +19,963 +8%
PHS
5
PFM Health Sciences
California
$147M
JP Morgan Chase
6
JP Morgan Chase
New York
$140M +$31.3M +45,866 +32%
AllianceBernstein
7
AllianceBernstein
Tennessee
$113M +$36.9M +54,209 +56%
Wells Fargo
8
Wells Fargo
California
$104M +$38.6M +56,697 +68%
PA
9
Perceptive Advisors
New York
$98.4M -$18M -26,460 -17%
CIP
10
Champlain Investment Partners
Vermont
$92.3M +$30.9M +45,405 +57%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$76.7M -$100M -147,281 -59%
State Street
12
State Street
Massachusetts
$51.1M +$4.98M +7,309 +12%
Citadel Advisors
13
Citadel Advisors
Florida
$50.4M +$16.2M +23,766 +54%
TCM
14
TimesSquare Capital Management
New York
$50.2M -$253K -372 -0.5%
Jennison Associates
15
Jennison Associates
New York
$50M +$13.5M +19,825 +42%
RI
16
RTW Investments
New York
$44.2M +$7.15M +10,500 +21%
Fidelity International
17
Fidelity International
Bermuda
$41.3M +$28.2M +41,400 +291%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$36.1M +$7.79M +11,425 +31%
PVI
19
Pura Vida Investments
New York
$26.8M +$7.65M +11,230 +45%
Massachusetts Financial Services
20
Massachusetts Financial Services
Massachusetts
$23.1M +$2.72M +3,994 +15%
BG
21
Bellevue Group
Switzerland
$22.6M
Bank of New York Mellon
22
Bank of New York Mellon
New York
$21.8M +$13.5M +19,805 +207%
Northern Trust
23
Northern Trust
Illinois
$21.6M +$766K +1,124 +4%
Morgan Stanley
24
Morgan Stanley
New York
$21.2M +$4.24M +6,216 +28%
WA
25
Wasatch Advisors
Utah
$20.6M +$18.9M +27,767 New

OM Hedge Fund Activity: Q3 2021 in Review

142 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2021, worth a combined $2.5B — up 8.5% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new OM positions and 13 closed out — a net gain of 13 holders — while 60 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $45.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $100M.

  • 142 institutional investors held Outset Medical (OM) as of Q3 2021, up from 129 in Q2 2021.
  • Funds reported $2.5B of Outset Medical stock for Q3 2021, up 8.5% quarter-over-quarter.
  • 26 funds opened new Outset Medical positions in Q3 2021 and 13 closed out, a net change of +13 holders.
  • The largest Outset Medical buyer in Q3 2021 was BlackRock, an estimated $45.4M added.
  • The largest Outset Medical seller in Q3 2021 was T. Rowe Price Associates, an estimated $100M sold.

Based on aggregated 13F filings for Q3 2021.